Sign in
Download Opera News App

STOCK INVESTMENT

Chinese firm's COVID-19 drug claims draw skepticism

Chinese firm's COVID-19 drug claims draw skepticism

Enlarge (Reuters) -Chinese biotech firm Kintor Pharmaceutical Limited saw its stock price jump by more than 20% the day after it announced on April 25 that it had “completed the first patient enrollment and dosing” in a late-stage U.S. clinical trial of its experimental COVID-19 treatment. It was the company’s latest announcement about...

Read Full Story
Chinese Kintor Kintor Pharmaceutical Lucy Lu Reuters Zeid Kayali

Top News

KIDNAPPING

This is what we know about those missing in the Miami condo collapse

edition.cnn.com
This is what we know about those missing in the Miami condo collapse

KIDNAPPING

This is what we know about those missing in the Miami condo collapse

edition.cnn.com

NBA

Surfside, Florida building collapse: Miami's pro sports teams lend helping hand to community in need

foxnews.com
Surfside, Florida building collapse: Miami's pro sports teams lend helping hand to community in need

NBA

Surfside, Florida building collapse: Miami's pro sports teams lend helping hand to community in need

foxnews.com

comments

Load app to read more comments